FL-101 in Surgically Resectable Non-Small Cell Lung Cancer

Summary

Phase 2 trial to study FL-101 alone or in combination with nivolumab in patients who have surgically resectable Non-Small Cell Lung Cancer.

Timeline

Start

2021-08-25

Primary completion

2021-12-22

Completion

2021-12-22

Outcome

Outcome not reported

Stopped (Business): “Sponsor Decision”

Drugs

Indications